Metabolic screening

Diabetes Screening Inadequate in Mentally Ill

New research shows that despite long-standing recommendations that severely mentally ill patients who take antipsychotics undergo annual screening for diabetes and other metabolic disorders, only 30% receive such screening. A recent research letter in JAMA Internal Medicine described a¬†retrospective cohort study that analyzed diabetes screening prevalence and predictors of screening among adults in the California […]

Read More
DETAIL

Essential Components of First-Episode Psychosis Services

A study published in May 1st, 2013 Psychiatric Services identified essential evidence-based components of first-episode psychosis services. The research took place in two stages. First a systematic literature review, then, a consensus-building technique, the Delphi, was used with an international panel of experts. The panelists were presented the evidence-based components identified in the review, together […]

Read More
DETAIL

Non-adherence to Antipsychotics and Cardiometabolic Medication Result in Health Care Utilization and Costs

A new study in Psychiatric Services examined the association between adherence to antipsychotic and cardiometabolic medication and the use of health care services and expenditures. A total of 87,015 unique patients with schizophrenia who received at least one antipsychotic medication were reviewed via Medicaid files from 2004 to 2008. An annual cross-sections of patients with […]

Read More
DETAIL

Linking Mental Illness To Chronic Physical Illness Risk

Results from a study by Substance Abuse and Mental Health Services Administration (SAMHSA) demonstrated that individuals aged 18 and older who had any mental illness, major depressive episodes or serious mental illness in the past year, are more likely to have a strke or develop diabetes, high blood pressure, asthma, cardiovascular disease, than those who […]

Read More
DETAIL

Impact of Preexisting Metabolic Risk Factors on the Choice of Antipsychotics

A study in this month’s Psychiatric Services examined the association between patients’ preexisting metabolic risk factors and the physician’s choice of antipsychotic agent based on its propensity to cause metabolic side effects. Over a span of 3 years, 1,898 office-based visits were identified during which prescriptions of antipsychotics were mentioned. Antipsychotics were classified as having […]

Read More
DETAIL

Psychiatrists fail to monitor patients for metabolic side-effects of medication

According to a new study in Psychological Medicine, people treated in psychiatric settings are receiving inadequate medical monitoring while taking antipsychotic medication New research from the University of Leicester demonstrates that psychiatrists are not offering adequate checks for metabolic complications that are common in patients prescribed antipsychotic medication. Patients treated with antipsychotic medication, especially those […]

Read More
DETAIL